The reported product is not expected to be returned as the device was reportedly discarded.A valid serial number has not been provided.An extended investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.Clinical data was reviewed and confirmed that libre sensors continue to be safe, effective, and perform as intended in the field.Stability data for libre sensors was reviewed and showed no anomalies or non-conformances that could have lead to the complaint.A tripped trend review was conducted for the reported complaint and fs libre sensors, no trends were identified that would indicate any product related issues.In the event that unanticipated product is received, a physical investigation will be performed per adc's established processes and procedures and a follow-up report will be submitted upon completion of investigation.The device manufacturing date is unknown.The date entered is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
|
A high reading issue was reported with the adc device.The customer obtained a sensor scan of 88 mg/dl; however, customer began to experience double vision.After an unspecified time, the customer indicated they could not move anymore, fell down, and was taken to the hospital where a glucose result of 44mg/dl was obtained on the healthcare meter compared to sensor reading of 88mg/dl.The results, when plotted on a parkes error grid, fell into the 'c' zone showing the difference in values to be clinically significant.The customer received intravenous glucose 10% for treatment and ct scan was performed.There was no report of death or permanent injury associated with this event.
|